We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Digital Supplement | Editorially independent content supported by Amaros, Atia Vision, Aurion Biotech, Azura Ophthalmics, EyeYon Medical, Iantrek, PLU Ophthalmic, SpyGlass Pharma, Tenpoint Therapeutics, and ViaLase.

Visionary Breakthroughs

Among medical specialties, ophthalmology has always enjoyed a rapid pace of innovation. Across its subspecialties, the field continues to deliver transformative breakthroughs, driven by a diverse range of technological advancements including lasers, wavefront analysis, microincisional techniques, high-resolution imaging, implantable devices, adaptive optics, biocompatible materials, and pharmaceutical developments.

Now, as artificial intelligence (AI) introduces unprecedented computational capabilities into research and development, the momentum behind ophthalmic innovation is poised to accelerate further—broadening both its scope and its impact on future patient care.

Bryn Mawr Communications—the publisher of Cataract & Refractive Surgery Today, Glaucoma Today, and Eyetube, among other leading platforms—presents this special supplement to spotlight some of the most exciting developments redefining the future of ophthalmology. What follows is an overview of innovations that are reshaping the way clinicians will diagnose, treat, and care for patients.

NEXT IN THIS ISSUE